Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential - Wikidata - wikimedia - TriplyDB

Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential

Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential

http://www.wikidata.org/entity/Q27027795

about

Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration Tracheal reconstruction with a free vascularized myofascial flap: preclinical investigation in a porcine model to human clinical application.Clinical Considerations for Vascularized Composite Allotransplantation of the Eye.An engineered multicomponent bone marrow niche for the recapitulation of hematopoiesis at ectopic transplantation sites.Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.

P2860

Q26770126-C17DA3AA-B27F-44B2-866F-93114297623F Q36669753-69800064-E45E-4C6F-863E-507B4BC94FBB Q41565697-E1666776-EF2A-4FC9-AA0D-21D69E080290 Q41647397-4C486DEC-7E7A-4359-B4DF-C2A6F879830F Q42694906-787EAFD7-7227-4F09-AC36-8246A8483862 Q54936269-140360D2-2F7B-4C54-838E-ECF1F3E4E813

P2860

Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential

http://www.wikidata.org/entity/Q27027795

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Site-specific immunosuppressio ...... ation: prospects and potential

@ast

Site-specific immunosuppressio ...... ation: prospects and potential

@en

Site-specific immunosuppressio ...... ation: prospects and potential

@nl

type

label

Site-specific immunosuppressio ...... ation: prospects and potential

@ast

Site-specific immunosuppressio ...... ation: prospects and potential

@en

Site-specific immunosuppressio ...... ation: prospects and potential

@nl

prefLabel

Site-specific immunosuppressio ...... ation: prospects and potential

@ast

Site-specific immunosuppressio ...... ation: prospects and potential

@en

Site-specific immunosuppressio ...... ation: prospects and potential

@nl

P1433

Q27027795-287F06F7-144B-4C1B-BC4C-C838E6C1C358

P1476

Q27027795-A15BEB35-570E-4535-843E-977F5084E78E

P2093

Q27027795-62E02FB4-BD36-48C4-B20D-8AD26186E0EC

Q27027795-6EBF4A85-D820-4F8E-9C4E-E3116174DFDE

Q27027795-7F7004E6-4C6C-4B3C-B3E2-0BD1AE295396

Q27027795-BF240208-EDF5-406D-818D-7E25B3562BA3

Q27027795-D1178CBA-7F76-4195-8253-C3825C7B0D24

Q27027795-D7B5AE29-4FF1-420C-BFCB-FAF9444E5372

Q27027795-D8DF3A9F-00CA-43F5-8F5F-C8BE8AE79329

P275

Q27027795-21C43B9D-00DE-4B50-9383-D20BE75CBC69

P2860

Q27027795-011A2E3C-32DA-4C9D-85E2-327DF42606C2

Q27027795-0CED9FB8-0579-4492-B556-C78713121176

Q27027795-12401C23-B80D-49E9-A331-88FA63BDA7A7

Q27027795-12D29834-24EE-4CDE-8871-8AAC52400FFD

Q27027795-17307F33-9651-4BD8-94A6-919E16F0C4ED

Q27027795-18288681-1EEF-462A-A6DD-6468439AA6DE

Q27027795-204AA769-9886-4B2C-8F31-0398FFF85EEE

Q27027795-23D21E58-C5FA-4E07-ACBF-D67955FB3F21

Q27027795-305DBC50-54A5-4622-958F-BFB8CC6BCAD7

Q27027795-3D532714-BD43-424A-8040-A63AF2DFF9DF

P304

Q27027795-8D1E6F43-78D8-4616-A169-9047FCA1BF7B

P31

Q27027795-536EDC37-6448-4970-BC44-2D624DDF242A

Q27027795-A9B3E809-5CB7-4BFF-92C5-AE6F9952B944

P356

Q27027795-D26A00C6-9FC2-44B6-A705-DD009A55A3CC

P407

Q27027795-98FBC8A9-9094-4167-A7BA-FBCD62DDB60B

P478

Q27027795-785FEAD9-D7AA-47B6-B662-C799F38E8569

P577

Q27027795-70C4E7E9-FF62-4DA0-8F3D-B67882873C7E

Q27027795-E2857B21-E730-4CAD-96CD-3E12027F7D98

P5875

Q27027795-8822D14E-A29E-43C7-B9D4-50E905DF7DF1

P698

Q27027795-C47A7859-F329-41CE-96A6-DACE5D71DB48

P921

Q27027795-6ED1BDFE-1E41-4CFD-AB65-08728E886E39

Q27027795-76A38696-067E-44D5-A00B-6600BCB459A3

Q27027795-B9B0D2BD-DFC8-4282-850C-693037A5485D

P932

Q27027795-62CFB34B-DCC6-47F5-8E03-1735809DF51D

P356

P1433

Clinical and Developmental Immunology

P1476

Site-specific immunosuppressio ...... ation: prospects and potential

@en

P2093

Jan A. Plock

http://www.w3.org/2001/XMLSchema#string

Jonas T. Schnider

http://www.w3.org/2001/XMLSchema#string

Mario G. Solari

http://www.w3.org/2001/XMLSchema#string

Matthias Weinstock

http://www.w3.org/2001/XMLSchema#string

Raman Venkataramanan

http://www.w3.org/2001/XMLSchema#string

Vijay S. Gorantla

http://www.w3.org/2001/XMLSchema#string

Xin Xiao Zheng

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Dendritic cells and the control of immunity

Penetration enhancers

Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation.

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.

Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies.

Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response.

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.

Tacrolimus ointment is effective for facial and intertriginous psoriasis.

A position statement in support of hand transplantation.

P304

495212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/495212

http://www.w3.org/2001/XMLSchema#string

P407

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235897143

http://www.w3.org/2001/XMLSchema#string

P698

23476677

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

biomedical investigative technique

P932

3586464

http://www.w3.org/2001/XMLSchema#string